Jason Barlow Email & Phone Number

Chicago, IL, US

Basel, Baselstadt, CH

• Supported development of the Zolgensma gene therapy scientific narrative, Scientific Communication Platform (SCP), and SMA Clinical Evidence Resource Pack
• Publications experience preparing congress abstracts posters and presentations, manuscript development and submissions, synthesizing feedback from internal and external authors
• Global Medical Communications supporting symposia, congresses, Medical Q&A & scientific messaging
• Primary Medical reviewer on Product Review Committee PRC for Product Launch of Zolgensma for SMA
• Developed over 100 data-on-file documents to verify data from completed and ongoing open label clinical trials (STR1VE-US, STR1VE-EU, SPR1NT, START, STRONG, LT-001, LT-002)
• Highly knowledgeable of OAV-101 Clinical Program from a Medical Affairs Perspective

• Medical Communications Medical reviewer: Commercial gene therapy product launch
• Medical reviewer in the CMLR function reviewing Immunology content for Commercial, Medical, and International through Veeva and Zinc (Shire)
• Managed the redevelopment of over a dozen field facing TA and product slide decks for Immunology Global Medical Affairs (Baxalta)
• Supporting commercial messaging of new clinical data for an approved ophthalmology medication (Genentech)
• Assessment of an infusion pump for use in an ambulatory setting
• Facilitated expert interviews to understand products in development for psoriasis (Janssen)

Paris, FR

• Provided Competitive Intelligence (CI) for Astellas:o Proposed plan for the incentive compensation for a client promoting 2 products for same indicationo Completed planning assessment of workflow and work capacity of.
• Created drug product competitive landscape assessments of all products in clinical development for NHL, AML, NSCLC and prostate cancer including timelines predicting product launches until 2020
• Developed launch starter kit, launch plan, and background presentation for antifungal product
• Facilitated workshop to create new strategies and approaches to treat nociceptive and neuropathic pain (Teva)

• Strategic Consulting including:
• Provided commercial and new product evaluations of small molecules and biologics for pharmaceutical, and bio-pharmaceutical companies, for example: o Provided competitive intelligence about biosimilars and drug.
• Produced revenue forecasts for products and MS Excel-based financial modeling
• Prepared compelling reports and presentations detailing market research and development efforts
• Skilled at interviewing key opinion leaders, physicians, nurses and other health care professionals

Chicago, IL, US

• Played an active role in commercial and new product evaluations of small molecules, biologics, and medical devices for hedge funds, pharmaceutical, and bio-pharmaceutical companies
• Devised a no-go recommendation for a company’s planned medical device acquisition after revealing poor physician acceptance and minimal medical need
• Provided valuations of large, multi-national drug product portfolios, which proved instrumental in securing private equity funding that infused business expansion
• Crafted a positioning strategy for a next generation drug that achieved clear differentiation from others in the same class
• Conducted primary market research as a liaison to over 200 prescribing physicians and Key Opinion Leaders
• Produced revenue forecasts and modeling

Foster City, CA, US

• Evaluated commercial opportunities within 4 immunology therapeutic areas, including chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, and Crohn’s disease
• Examined market potential of products in development as compared to approved products
• Conducted competitive analysis and reviewed products with Key Opinion Leaders to gain insight
• Primary author responsible for developing 4 presentations and white papers for senior management
• Received executive approval for product recommendations and transition to business development
• Utilized IMS, IDdb3, Citeline, Decision Resources, Trial Trove, Tandem Cancer Audit and Prous Science Integrity databases

Stanford, CA, US

• Stanford Graduate School of Business: Completed four MBA courses, including Business Plan Development, Innovation in Neurologic Disease, Ethics in the Pharmaceutical Industry, Careers in Life Science.
• Research Highlights: Studied B cell development using a mouse model. Discovered a key gene regulator involved in cell division relevant to lymphoma with implications for new treatments.

Stanford, CA, US

• Co-developed a science consultation for a business plan that was crucial to the launch of ConfometRx Inc., a start-up company that originated at Stanford University
• Worked closely with the chairman of Nektar Therapeutics to commercialize a technology for the production of GPCR protein, the richest source of drug targets. Subsequently led to an agreement with Medarex Inc. as the.

Stanford, CA, US

• Developed an innovative medical device concept to treat brain strokes as a partner to a four-person interdisciplinary team which won an entrepreneurial award for this effort.
• The technology combined a shape memory polymer with a bioabsorbable stent
• Called the Memostent Project our idea was judged the most likely to succeed by Silicon Valley Venture Capitalists

• Managed a $1 million dollar annual operating budget for an 84-unit apartment building
• Generated a budget surplus over four years consecutively and significantly increased investment returns on reserve funds
• Doubled the replacement reserve contribution to $50,000 per year and limited rent increases due to cost-savings measures via contracts with utilities providers

Waterloo, Ontario, CA

• Optimised and performed cell proliferation experiments with rainbow trout cell lines, published
• Studied the effect of glutamine and mitogens on mitogenesis

Ottawa, Ontario, CA

• Assisted in the development of a diagnostic for carcinogenesis, a precursor to gene chips
• Co-designed a diagnostic test for rapid determination of chemical carcinogenesis
• Gained skills in animal cell culture, mRNA purification, reverse transcription, dot blots, Northern blots, plasmid extraction, restriction enzyme digestion, and use of radioisotopes
• Published

Toronto, ON, CA

• Actively participated in development of a point-of-care diagnostic testing product for heart attack, which accelerated testing and provided immediate data without waiting for laboratory results
• Purified recombinant cardiac proteins grown from bacterial cell culture. Utilized ion exchange chromatography, ultrafiltration, dialysis, Bradford protein assay, and Western blotting
• Determined the isoelectric point of recombinant proteins, such as myosin light chain

Gatineau, Quebec, CA

• Identified sources, accumulation, distribution, and degradation of mixed function oxidase (p450) inducing compounds in pulp mill effluent and their effect on rainbow trout

• Analysed sewage and industrial effluent for ammonia, BOD, suspended solids, oil and grease
• Assessed the impact of Cryptosporidium, a waterborne parasite, on the local water supply

• Prepared mineral samples for analytical analysis monitoring smelting efficiency
• Analysed mineral samples using inductively coupled and direct current plasma spectroscopy

• Produced evacuated blood collection tubes, established operating protocols for new products
• Trained personnel in assembly line operation and implemented changes improving productivity

Ph.D, Medical Biophysics

B.Sc, Biology